Applied Clinical Trials
April 01, 2015
View from Brussels
35
3
Media rebuke of Europe’s Innovative Medicines Initiative thrusts debate into the public arena.
April 01, 2015
CTI Insights
35
3
Study shows that industry contributions to R&D go well beyond the applied area of clinical testing.
April 01, 2015
Feature Article
35
3
Successful conduct of hematological malignancy trials requires addressing several unique complexities.
April 01, 2015
Feature Article
35
3
How the practical application of these methods can help overcome the complex demands of cancer trials.
April 01, 2015
Feature Article
35
3
Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.
April 01, 2015
A Closing Thought
35
3
The need for robust and standardized psychiatric outcomes measures in oncology trials has grown immensely
April 01, 2015
Feature Article
35
3
Building a structure for managing study operations through linking trial- and site-level forecasting.
April 01, 2015
News
35
3
Faster go/no-go decisions is the primary driver of adaptive-design adoption by sponsors.
April 01, 2015
News
35
3
The productivity of the U.S. biomedical research enterprise is undergoing a broad re-examination.
April 01, 2015
News
35
3
Initiative designed to boost understanding of medical device development in Europe.
April 01, 2015
News
35
3
Patient focused drug development is playing a larger role in study design and outcome measurement.
April 01, 2015
News
35
3
New ASCO study evaluating the cancer care system reveals mixed findings.
April 01, 2015
News
35
3
Outlining the requirements and benefits of FDA's four expedited drug approval pathways.
April 01, 2015
News
35
3
Following four key study-design steps is crucial to the delivery of a successful cross-border cancer study
April 01, 2015
Issue PDF
35
3
Trial Design: Breaking Blood Cancer Barriers Adaptive Solutions in Oncology Clinical Technology: Tumor Imaging Ascension Sites: Enrollment Forecast Data Also in this issue: Innovation Initiative Debate in Europe R&D Investment: Public vs. Private The Psychology of Cancer